Efficacy and Safety of Ertugliflozin in Patients With Diabetes Mellitus Inadequately Controlled by Sulfonylurea Monotherapy: a Substudy of VERTIS CV

INTRODUCTION: Sulfonylureas (SU) are commonly used antihyperglycemic agents. VERTIS CV was the cardiovascular outcome study for the sodium-glucose cotransporter 2 inhibitor ertugliflozin. Enrollment of patients in VERTIS CV occurred in two sequential cohorts (Cohort 1 and Cohort 2). METHODS: This su...

Descripción completa

Detalles Bibliográficos
Autores principales: Strojek, Krzysztof, Pandey, A. Shekhar, Dell, Vanessa, Sisson, Melanie, Wang, Shuai, Huyck, Susan, Liu, Jie, Gantz, Ira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994479/
https://www.ncbi.nlm.nih.gov/pubmed/33694093
http://dx.doi.org/10.1007/s13300-021-01018-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994479/
https://www.ncbi.nlm.nih.gov/pubmed/33694093
http://dx.doi.org/10.1007/s13300-021-01018-w

Ejemplares similares